LUXEMBOURG (CN) — An adviser to the European Union’s top court said Thursday it should reject a pharmaceutical company’s challenge to a penalty for paying to delay the sale of generic drugs, finding such deals violate EU competition rules.
LUXEMBOURG (CN) — An adviser to the European Union’s top court said Thursday it should reject a pharmaceutical company’s challenge to a penalty for paying to delay the sale of generic drugs, finding such deals violate EU competition rules.